- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The LNG regasification segment is set to dominate upcoming oil and gas midstream projects in China, accounting for about 47% of the midstream projects starting between 2024 and 2028, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Asia-Pacific Oil and Gas Projects by Development Stage, Capacity, Capex, Contractor Details of All New […]
Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications, says GlobalData
Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received FDA approval for use in adults aged 60 years and older, marking the first time that an mRNA vaccine has been approved for a disease other than COVID-19. This approval represents a significant development in the field and will likely encourage the use of mRNA technology […]
Biopharmaceutical industry’s growth optimism surges but lags behind 2022 levels, says GlobalData
The biopharmaceutical industry is showcasing increasing optimism regarding its growth prospects over the next 12 months. While the upward trend is a positive sign, it remains below the levels of confidence seen in 2022, finds GlobalData, a leading data and analytics company. In a recent GlobalData’s survey*, “The State of the Biopharmaceutical Industry 2024 (mid-year […]
Biopharmaceutical industry remains mixed over EU reform proposals, finds GlobalData
Reforms to the European Union’s (EU) general pharmaceutical legislation emerge as one of the key policy developments affecting the operating environment for the pharma industry. In a survey, respondents’ opinions on the impact of EU reform proposals were mixed, with the percentage of participants expressing positive, negative, or neutral views remaining varied, according to GlobalData, […]
GlobalData unveils AI governance framework to help companies implement AI responsibly and safely
Artificial Intelligence (AI) risks can seriously tarnish a company’s reputation. Potential issues range from copyright infringement to data privacy breaches and the risk of actual physical harm. Increased use of AI will also reinforce and exacerbate many of the society’s biggest challenges, including bias, discrimination, misinformation, and other online harms. Hence, to help companies implement […]
Amylyx’s efforts to explore other indications for Relyvrio seem to be bearing fruit, says GlobalData
In March 2024, Amylyx Pharmaceuticals announced that Relyvrio, a neuroprotective agent, failed to achieve its primary efficacy endpoints in the global Phase III PHOENIX trial for amyotrophic lateral sclerosis (ALS). Relyvrio/Albrioza was first approved in the US and Canada in September 2022 for the treatment of ALS. However, following the monumental setback, on April 4, […]
ADHD market to decline by over $900 million in 7MM during 2022-32, forecasts GlobalData
The attention-deficit/hyperactivity disorder (ADHD) market across the seven major markets (7MM*) is forecast to decline at a negative compound annual growth rate (CAGR) of 0.8% from $11.9 billion in 2022 to $11.0 billion in 2032, driven by patent expiries, high generic uptake in the largest ADHD market, namely the US, and limited innovator entrants, according […]
PROTACs oncology market to hit $3.7 billion by 2030 despite lack of approved therapies, says GlobalData
Proteolysis targeting chimeras (PROTACs) are a promising approach to cancer treatment, yet after over two decades of research, not a single PROTAC has gained FDA approval. PROTACs are novel bifunctional compounds that promote the degradation of a protein of interest (POI) by connecting a POI ligand to an E3 ubiquitin ligase (E3) ligand through a […]
IGNAZ trial interim results highlight HI-Bio’s potential to differentiate in IgAN space, says GlobalData
At this year’s European Renal Association, positive results were presented from Human Immunology Bioscience’s (HI-Bio) interim results of the Phase II IGNAZ clinical trial. According to the results, the use of MOR-202 (felzartamab) demonstrated a deep and durable reduction in proteinuria in patients with immunoglobulin A (IgA) nephropathy (IgAN). The drug potentially fills an unmet […]
Rapid digitalization of agriculture sector increasing cybersecurity risks, says GlobalData
The adoption of technologies like robotics, artificial intelligence (AI), and the Internet of Things (IoT) across the agriculture sector is helping tackle various challenges, including labor shortages and climate change. However, this digitalization also puts the sector at risk of cyberattacks, says GlobalData, a leading data and analytics company. GlobalData’s latest thematic intelligence report, “Cybersecurity […]
GlobalData highlights importance of CMV tests during National Congenital Cytomegalovirus Awareness Month
National Congenital Cytomegalovirus Awareness Month is observed in June every year to raise awareness over cytomegalovirus (CMV), a common virus that typically causes mild or asymptomatic infections in individuals with healthy immune systems. However, when it comes to congenital CMV, the virus can have severe consequences for newborns, including permanent hearing loss, neurodevelopmental delays, and […]
Verona’s Ensifentrine attracts positive opinions in light of anticipated US launch for COPD, says GlobalData
Verona Pharma recently announced that they are finalizing preparations for a potential US launch of Ensifentrine in the third quarter of 2024, depending upon the FDA’s approval, set for June 26, 2024. The first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor aims to reduce exacerbations in chronic obstructive pulmonary disease (COPD) patients, administered as a nebulized formulation. […]
UFC and DraftKings partnership tops gambling and betting sector’s sport sponsorship deals in Americas, reveals GlobalData
American gambling and betting brands dominate the sports sponsorship spend across the Americas region. The top 10 largest deals are heavily dominated by the big four major sports leagues in the Americas, which include the National Football League (NFL), the National Basketball Association (NBA), the National Hockey League (NHL), and Major League Baseball (MLB). However, […]
Quantum internet poised to revolutionize global connectivity, finds GlobalData
The advent of the quantum internet, a revolutionary communication system utilizing quantum mechanical principles and qubits instead of binary bits, is poised to redefine global connectivity with unprecedented levels of security and performance. This transformative technology holds the potential to transform many industries, including telecommunications, cybersecurity, and computing, according to GlobalData, a leading data and […]
Osteoporosis Awareness & Prevention Month highlights need for prioritizing early diagnosis and advanced treatments, says GlobalData
The Bone Health and Osteoporosis Foundation (BHOF) observes the month of May every year as Osteoporosis Awareness & Prevention Month to shed light on the critical needs of those living with osteoporosis. Advocates emphasize the importance of enhancing education, research, and healthcare strategies to tackle this prevalent, yet frequently neglected condition. Prioritizing prevention, early diagnosis, […]
Romania’s military modernization efforts to offer market entry routes for defense firms, says GlobalData
As a former member of the Warsaw Pact, Romania still possesses large volumes of aging Cold War equipment. In order to meet North Atlantic Treaty Organization (NATO) standards, Romania can either outright replace such models with modern, Western equipment or heavily modify units to bring these platforms in line with NATO’s STANAG (Standardization Agreement) documents. […]
EA Sports biggest sports sponsorship tech brand in Americas in 2024, reveals GlobalData
Soccer is the most popular sport in terms of sponsorship agreements across the Americas region. EA Sport is the most active tech brand in the region, and one of the key drivers of its deal volume is its partnerships with several American football teams, including the Tampa Bay Buccaneers, Philadelphia Eagles, and Kansas City Chiefs. […]
AbbVie’s strong immunology portfolio to offset Humira losses, says GlobalData
For 20 years, AbbVie’s Humira (adalimumab) has been one of the world’s top-selling products. However, the US drug expiry in January 2023 resulted in a 32% decline in sales of Humira in 2023, accompanied by a 7% drop in the company’s total revenue for that year. As further sharp declines are expected for Humira, AbbVie […]
Indian startups raise $3.1 billion in VC funding during January-April 2024, finds GlobalData
Indian funding winter seems to be waning as the country witnessed year-on-year (YoY) improvement in venture capital (VC) funding deals volume and value during January-April 2024. A total of 375 VC funding deals were announced in the first four months of 2024 while the disclosed value of these deals stood at $3.1 billion. This was […]
India to significantly contribute to global butadiene capacity additions through 2028, says GlobalData
India’s butadiene market is set to experience a significant growth trajectory through 2028, contributing about 18% of the global butadiene capacity additions from six new build and expansion projects, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Butadiene Industry Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants […]